What they were paid
GALECTIN THERAPEUTICS Director Compensation Table · the one fiscal year held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2024 | $56,000 | $0 | $58,000 | $0 | $114,000 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: GALECTIN THERAPEUTICS INC DEF 14A filed October 22, 2025, accession 0001140361-25-038875, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2024GALECTIN THERAPEUTICS pays directors a $35,000 cash retainer.
Committees
FY2024 · as the proxy prints themAudit · Compensation · Nominating/Governance
The rest of the GALECTIN THERAPEUTICS board
FY2024 · as the company reported each| Director | Role | FY2024 total |
|---|---|---|
| Benjamin S. Carson Sr., M.D | Director | $98,000 |
| Elissa J. Schwartz, Ph.D | Independent Director | $101,500 |
| Gilbert F. Amelio, Ph.D | Independent Director | $113,500 |
| Gilbert S. Omenn, M.D., Ph.D | Independent Director | $108,000 |
| Harold H. Shlevin, Ph.D | Independent Director | $98,000 |
| Joel Lewis | Director | $0 |
| Kary Eldred | Independent Director | $105,500 |
| Marc Rubin, M.D | Independent Director | $101,500 |
| Richard A. Zordani | Independent Director | $113,000 |
| Richard E. Uihlein | Independent Director | $98,000 |
The full GALECTIN THERAPEUTICS compensation record
free company briefThis page is one director within GALECTIN THERAPEUTICS's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat